CONNECTIONS BETWEEN OBESITY AND COLORECTAL CANCER. THE ROLE OF INFLAMMATION MEDIATED BY GHRELIN AXIS IN THE ADIPOSE TISSUE

  • Raluca Ecaterina HALIGA “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • D. V. TIMOFTE “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Bianca Codrina MORARASU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • F. ZUGUN-ELOAE “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Mihaela PASCARU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Veronica MOCANU “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Abstract

CONNECTIONS BETWEEN OBESITY AND COLORECTAL CANCER. THE ROLE OF INFLAMMATION MEDIATED BY GHRELIN AXIS IN ADIPOSE TISSUE (Abstract): Obesity and colorectal cancer are two major global health issues. Although they seem to lack a clear connection, epidemiologic analysis found a significant association. This led to further evaluation and identification of molecular pathways that stand at the basis of these findings. One of them is chronic inflammation, a state associated with obesity and colorectal cancer. Adipose tissue from obese individuals suffers a pathogenic switch responsible for higher inflammatory capacity. This modulates the interplay between inflammation and colorectal cancer cells. Through growth factors and cytokines, adipose tissue creates a favorable microenvironment for tumor development. Our focus is on the ghrelin-growth hormone secretagogue receptor axis which promotes inflammation and has mitogenic and antiapoptotic capacity on cancer cells, acting through various mechanisms including via TNF-α which promotes tumor cell proliferation, growth and metastasis and IL-6, a molecule associated with tumor size and stage in colorectal cancer patients. 

Author Biographies

Raluca Ecaterina HALIGA, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (I)

D. V. TIMOFTE, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Surgery (I)

Bianca Codrina MORARASU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Morpho-Functional Sciences (II)

F. ZUGUN-ELOAE, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Morpho-Functional Sciences (II)
Regional Institute of Oncology, Iasi
TRANSCEND Research Center 

Mihaela PASCARU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Regional Institute of Oncology, Iasi
TRANSCEND Research Center

Veronica MOCANU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Morpho-Functional Sciences (II)

References

1. ***World Health Organization. Fact sheets; 18 October 2017. Available from: http://www.who.int/en/ news-room/fact-sheets/detail/obesity-and-overweight.
2. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638.
3. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body Mass Index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578.
4. Ligibel JA, Alfano CM, Courneya KS, Demark-Wahnefried W, Burger RA, et al. American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol 2014; 32: 3568-3574.
5. ***Cancer Facts & Figures. Cancer.org 2016. http://www.cancer.org.
6. Ouakrim DA, Pizot C, Boniol M, Malvezzi M, Boniol M, Negri E, et al. Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database. BMJ 2015; 351: h4970.
7. Polednak AP. Estimating the number of U.S. incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-related cancers. Cancer Detection and Prevention 2008; 32(3): 190-199.
8. Harriss DJ, Atkinson G, George K, et al. Lifestyle factors and colorectal cancer risk: systematic review and meta-analysis of associations with body mass index. Colorectal Disease 2009; 11(6): 547-563.
9. MacInnis RJ, English DR, Haydon AM, Hopper JL, Gertig DM, Giles GG. Body size and composition and risk of rectal cancer. Cancer Causes Control 2006; 1(7): 1291-1297.
10. Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2006; 2(4): 367-373.
11. Bays HE, Toth PP, Kris-Etherton PM, Abate N, Aronne LJ, Brown WV, et al. Obesity, adiposity and dyslipidemia: a consensus statement from the National Lipid Association. J Clin Lipidol 2013; 7(4): 304-383.
12. Arnold M, Pandeya N, Byrnes G, Renehan AG, Stevens GA, Ezzati M, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol 2015; 16: 36-46.
13. Bhaskaran K, Douglas I, Forbes H, Dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet 2014; 384: 755-765.
14. Kursawe R, Eszlinger M, Narayan D, Liu T, Bazuine M, Cali AM, et al. Cellularity and adipogenic profile of the abdominal subcutaneous adipose tissue from obese adolescents: association with insulin resistance and hepatic steatosis. Diabetes 2010; 59(9): 2288-2296.
15. Hao NB, Lü MH, Fan YH, Cao YL, Zhang ZR, Yang SM. Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol 2012: 948098.
16. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48(4): 526-535.
17. Bardou M, Barkun AN, Martel C. Obesity and colorectal cancer. Gut 2013; 62(6): 933-947.
18. Toshinai K, Mondal MS, Nakazato M, Date Y, Murakami N, Kojima M, Kangawa K, Matsukura S.Upregulation of ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem Biophys Res Commun 2001; 281: 1220-1225.
19. TschöpM, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000; 407: 908-913.
20. Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50(4): 707-709.
21. Bustin SA, Jenkins PJ. The growth hormone-insulin-like growth factor-I axis and colorectal cancer. Trends Mol Med 2001; 7(10): 447-454.
22. Kawaguchi M, Kanemaru A, Fukushima T, Yamamoto K, Tanaka H, Haruyama Y, Itoh H, Matsumoto N, Kangawa K, Nakazato M, Kataoka H. Ghrelin administration suppresses inflammation-associated colorectal carcinogenesis in mice. Cancer Sci 2015; 106(9): 1130-1136.
23. Liu Z, Brooks RS, Ciappio ED, Kim SJ, Crott JW, Bennett G, et al. Diet-induced obesity elevates colonic TNF-α in mice and is accompanied by an activation of Wnt signaling: a mechanism for obesity-associated colorectal cancer. J NutrBiochem 2012; 23(10): 1207-1213.
24. Harvey AE, Lashinger LM, Hursting SD. The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y AcadSci 2011; 1229: 45-52.
25. Stanilov N, Miteva L, Dobreva Z, Stanilova S.Colorectal cancer severity and survival in correlation with tumour necrosis factor-alpha. Biotechnol Equip 2014; 28(5): 911-917.
26. Waldner MJ,Foersch S,Neurath MF. Interleukin-6 -A key regulator of colorectal cancer development. Int J BiolSci 2012; 8(9): 1248-1253.
Published
2018-10-02
Section
INTERNAL MEDICINE - PEDIATRICS